当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析 - 资产负债表

西藏药业

(600211)

  

流通市值:111.00亿  总市值:111.00亿
流通股本:2.48亿   总股本:2.48亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金1,859,790,009.981,685,686,872.771,412,976,645.311,469,807,787.12
应收票据及应收账款666,557,742.21398,045,869.71642,759,348.44439,064,366.85
其中:应收票据15,628,037.111,130,283.462,473,965.672,309,606.02
应收账款650,929,705.1396,915,586.25640,285,382.77436,754,760.83
应收款项融资190,148,352.31250,644,780.91215,721,391.22239,034,910.84
预付款项13,517,754.4114,486,506.769,363,123.3612,519,318.82
其他应收款合计11,815,347.727,212,145.7713,798,308.8860,049,130.92
存货111,434,996.81115,520,102.56100,414,670.3494,807,424.46
其他流动资产34,261,490.5842,458,613.0823,294,505.2929,323,509.83
流动资产平衡项目0000
流动资产合计3,402,862,444.973,343,904,2263,478,404,506.983,294,996,916.72
非流动资产:
长期股权投资92,847,039.4103,467,492.69103,842,149.99103,737,389.84
其他权益工具投资11,000,00010,000,000--
其他非流动金融资产12,776,570.5519,840,00019,840,00019,840,000
投资性房地产134,073,958.87135,546,011.7137,243,278.07139,067,043.2
固定资产537,547,355.25393,689,151.17385,329,711.69390,822,081.78
在建工程60,710,481.02202,911,371.21216,809,574.76211,432,719.75
使用权资产2,070,711.792,234,571.61,472,218.211,464,434.22
无形资产202,464,930.82405,436,512.17415,376,707.69404,227,934.61
开发支出1,308,821.891,294,788.191,284,771.941,277,253.47
商誉8,876,674.018,876,674.018,876,674.018,876,674.01
长期待摊费用625,143.1880,751.391,082,628.851,257,811.79
递延所得税资产115,476,980.0985,235,253.6171,056,287.1370,296,369.3
其他非流动资产4,715,998.058,097,859.018,940,392.999,944,481.26
非流动资产平衡项目0000
非流动资产合计1,184,494,664.841,377,510,436.751,371,154,395.331,362,244,193.23
资产平衡项目0000
资产总计4,587,357,109.814,721,414,662.754,849,558,902.314,657,241,109.95
流动负债:
短期借款499,985,445.75755,521,575.35629,135,027.4540,366,833
应付票据及应付账款38,888,245.2144,480,870.943,203,982.8447,051,527.91
应付账款38,888,245.2144,480,870.943,203,982.8447,051,527.91
预收款项193,737311,975.4239,745.637,666.8
合同负债9,840,203.77,884,805.722,527,520.523,566,570.88
应付职工薪酬39,051,842.2219,053,573.1418,378,667.2618,751,933.75
应交税费99,693,692.9465,560,402.3162,934,039.7545,283,479.17
其他应付款合计494,655,500.16337,303,679.5562,295,914.94593,759,770.93
一年内到期的非流动负债882,455.06536,656.77594,098.48947,649.71
其他流动负债1,279,226.4934,621.63268,464.39380,313.86
流动负债平衡项目0000
流动负债合计1,184,470,348.441,231,588,160.721,319,577,461.181,250,145,746.01
非流动负债:
租赁负债1,125,428.841,963,315.141,025,854.94864,431.83
递延收益25,854,916.0827,633,095.3227,647,882.0527,512,668.78
递延所得税负债2,285,703.5613,968,703.9913,969,779.413,762,177.14
非流动负债平衡项目0000
非流动负债合计29,266,048.4843,565,114.4542,643,516.3942,139,277.75
负债平衡项目0000
负债合计1,213,736,396.921,275,153,275.171,362,220,977.571,292,285,023.76
所有者权益(或股东权益):
实收资本(或股本)247,937,843247,937,843247,937,843247,937,843
资本公积1,262,787,952.791,266,137,335.791,266,137,335.791,266,137,335.79
其他综合收益61,213,951.4177,899,989.8884,641,005.0371,648,552.34
盈余公积125,819,278.99125,819,278.99125,819,278.99125,819,278.99
未分配利润1,646,829,998.31,701,257,920.391,739,842,061.251,632,066,671.8
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,344,589,024.493,419,052,368.053,464,377,524.063,343,609,681.92
少数股东权益29,031,688.427,209,019.5322,960,400.6821,346,404.27
股东权益平衡项目0000
股东权益合计3,373,620,712.893,446,261,387.583,487,337,924.743,364,956,086.19
负债和股东权益合计4,587,357,109.814,721,414,662.754,849,558,902.314,657,241,109.95
公告日期2024-03-272023-10-272023-08-252023-04-28
审计意见(境内)标准无保留意见
TOP↑